- Home
- VINP vs CRMD Comparison
VINP vs CRMD Comparison
Compare VINP & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VINP | CRMD |
|---|---|---|
| Founded | 2009 | 2006 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 638.8M | 695.9M |
| IPO Year | 2020 | 2009 |
Fundamental Metrics
Financial Performance| Metric | VINP | CRMD |
|---|---|---|
| Price | $9.79 | $8.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | $14.00 | ★ $14.83 |
| AVG Volume (30 Days) | 62.3K | ★ 1.5M |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | ★ 5.72% | N/A |
| EPS Growth | N/A | ★ 780.00 |
| EPS | N/A | ★ 0.43 |
| Revenue | N/A | ★ $311,709,000.00 |
| Revenue This Year | $18.07 | $0.30 |
| Revenue Next Year | $12.74 | N/A |
| P/E Ratio | $24.41 | ★ $20.63 |
| Revenue Growth | N/A | ★ 617.03 |
| 52 Week Low | $9.20 | $6.13 |
| 52 Week High | $13.61 | $14.96 |
Technical Indicators
Market Signals| Indicator | VINP | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 40.65 | 59.75 |
| Support Level | $9.61 | $8.09 |
| Resistance Level | $10.24 | $9.03 |
| Average True Range (ATR) | 0.37 | 0.39 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 13.14 | 87.86 |
Price Performance
Historical ComparisonAbout VINP Vinci Partners Investments Ltd.
Vinci Compass Investments Ltd is an alternative investment platform in Brazil offering asset management, wealth management, and financial advisory services. The company comprises of six business lines i) Global IP&S, (ii) Credit (including public & private credit, opportunistic capital solutions, and agribusiness credit), (iii) Private Equity, (iv) Equities, (v) Real Assets (including real estate, infrastructure and forestry) and (vi) Corporate Advisory.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.